stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Stem Cell Clinical Trial for Severe Heart Failure Underway

Posted by anna@stemsave.com on May 13, 2018 11:00:00 AM

dgh

A mesenchymal stem cell treatment for patients with cardiac muscle degeneration and ventricular failure is being conducted at the MedStar Heart and Vascular Institute. The patients currently being recruited for the study are those who require left ventricular assist devices (LVADs) in order to pump their heart, and these patients are in severe stages of cardiac failure. In pre-clinical models, intravenous mesenchymal stem cell injections have greatly improved left ventricular function, which is responsible for pumping and pressurizing the blood to the rest of the body. Additionally, there was a significant decrease in the inflammatory response that is indicative of damaged cardiac muscles. By reducing inflammation researchers hope to not only provide immediate relief for the strained cardiac muscle, but also slow or stop the progression of heart failure.

Dr. Stephen Epstein, director of Translational and Vascular Biology Research at MedStar, comments, “What we found in preclinical studies is that you don’t have to get them into the heart. Inflammation is a systemic disorder and all you have to do is suppress this systemic inflammatory response without getting stem cells to any major extent into the heart.”

As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

The Future of Regenerative Medicine is Now™

 To view the full article, click here.

Topics: reversing heart failure, LVADs, stem cell therapy, regenerative medicine

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all